Clinical trial

Oxidative Stress and Cardiovascular Morbidity in Sleep Apnea-Hypopnea Syndrome…

NCT00487929 · Hospital Universitario La Paz, Other · Completed

Key facts

NCT number NCT00487929
Title Oxidative Stress and Cardiovascular Morbidity in Sleep Apnea-Hypopnea Syndrome (SAHS)
Official title Phase 4 Study of the Relationship Between the Oxidative Stress and the Development of Cardiovascular Complications in the Sleep Apnea-hypopnea Syndrome (SAHS). Effect of the Treatment With CPAP
Acronym OSCAMSA
Lead sponsor Hospital Universitario La Paz, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Sleep Apnea, Cardiovascular Diseases
Intervention type Device
Interventions nasal CPAP, Sham CPAP
Enrollment 100
Start date Jun 1, 2007
Primary completion Apr 1, 2012
Completion Oct 1, 2012
First posted Jun 19, 2007
Last update posted Apr 2, 2013
Countries Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies